​

Connect Biopharma Ownership | Who Owns Connect Biopharma?

OverviewForecastRevenueFinancialsChart

Connect Biopharma Ownership Summary

Connect Biopharma is owned by 40.40% insiders, and 59.59% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in Connect Biopharma shares.

CNTB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockConnect Biopharma-40.40%59.59%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251-93.33%1,582-99.93%-0.02%--100.00%--100.00%
Jun 30, 20251730.77%2,444,820-13.54%416.87%7250.00%3-25.00%
Mar 31, 202513-13.33%2,827,742-11.11%515.40%2-75.00%4300.00%
Dec 31, 20241536.36%3,181,0278.02%520.23%860.00%1-
Sep 30, 202411-8.33%2,944,726-1.06%518.33%566.67%1-75.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index23.32K0.04%-

CNTB Ownership FAQ

Who Owns Connect Biopharma?

Connect Biopharma shareholders are primarily institutional investors at 0.00%, followed by 40.40% insiders and 59.60% retail investors. The average institutional ownership in Connect Biopharma's industry, Biotech Stocks , is 45.24%, which Connect Biopharma falls below.

Does Blackrock own Connect Biopharma?

BlackRock is not among the top 10 institutional shareholders of Connect Biopharma.

Who is the top mutual fund holder of Connect Biopharma shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Connect Biopharma shares, with 0.04% of its total shares outstanding invested in 23.32K Connect Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools